Mereo BioPharma Group plc
MREO
$1.77
$0.0251.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -49.55M | -47.19M | -43.25M | -45.32M | -36.85M |
| Total Depreciation and Amortization | 1.12M | 1.08M | 1.09M | 1.10M | 1.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.39M | 12.31M | 9.70M | 17.35M | 8.51M |
| Change in Net Operating Assets | -1.88M | 623.00K | -369.00K | -3.33M | 7.22M |
| Cash from Operations | -32.92M | -33.17M | -32.83M | -30.20M | -20.03M |
| Capital Expenditure | -20.00K | -20.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.00K | -299.00K | -699.00K | -699.00K | -699.00K |
| Cash from Investing | -320.00K | -319.00K | -699.00K | -699.00K | -699.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -3.19M |
| Issuance of Common Stock | 487.00K | 47.49M | 47.00M | 47.00M | 58.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -833.00K | -918.00K | -853.00K | -813.00K | -730.00K |
| Cash from Financing | -346.00K | 46.57M | 46.15M | 46.19M | 54.69M |
| Foreign Exchange rate Adjustments | 2.28M | 745.00K | -233.00K | 2.71M | 502.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -1.00K | -1.00K |
| Net Change in Cash | -31.31M | 13.82M | 12.38M | 17.99M | 34.46M |